Results 131 to 140 of about 636,200 (242)

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document [PDF]

, 2012
The aim of the current Valve Academic Research Consortium (VARC)-2 initiative was to revisit the selection and definitions of transcatheter aortic valve implantation (TAVI) clinical endpoints to make them more suitable to the present and future needs of ...
Kirtane, Ajay J, Head, Stuart J, van Es, Gerrit-Anne, Rodés-Cabau, Josep, Hahn, Rebecca T, Mack, Michael J, Brott, Thomas G, Webb, John G, Vranckx, Pascal, Cutlip, Donald E, van Mieghem, Nicolas M, Windecker, Stephan, Piazza, Nicolo, Kodali, Susheel, Kappetein, Arie Pieter, Généreux, Philippe, Blackstone, Eugene H, Cohen, David J, Valve Academic Research Consortium, (VARC)-2, Krucoff, Mitchell W, Valve Academic Research Consortium-2,, Leon, Martin B, Kappetein, A Pieter, Mehran, Roxana, Serruys, Patrick W, Kappetein, A.P. (Arie Pieter), Brott, TG, Kirtane, AJ, Mack, M.J. (Michael), Mehran, R, Piazza, N. (Nicolo), van Mieghem, NM, Valve Academic Research Consortium-2, Leon, M.B. (Martin), Head, S.J. (Stuart), Brott, T.G. (Thomas), Es, G.A. (Gerrit Anne) van, Genereux, P, Blackstone, EH, Kodali, S, Es, Gerrit-anne, Kirtane, A.J. (Ajay), Cutlip, DE, Head, Stuart, Cutlip, D.E. (Donald), Rodés-Cabau, J. (Josep), Mieghem, N.M. (Nicolas) van, Lip, DEC, Piazza, Nick, Krucoff, MW, Hahn, RT, van Es, GA, Rodes-Cabau, J, Kappetein, Arie-Pieter, Cohen, D.J. (David J.), Krucoff, M. (Mitchell), Vranckx, P. (Pascal), Blackstone, E.H. (Eugene), Serruys, P.W.J.C. (Patrick), Webb, JG, van Mieghem, Nicolas, Webb, J.G. (John), Windecker, S.W. (Stephan), Cohen, DJ, Mack, MJ, Hahn, R.T. (Rebecca), Kodali, S. (Susheel), Serruys, PWJC (Patrick), Mehran, R. (Roxana), Leon, MB, Généreux, P. (Philippe), Windecker, S   +71 more
core   +4 more sources

Severely Thrombosed Transcatheter Aortic Valve 9 Months After Implantation

, 2015
Bioprosthetic aortic valve thrombosis is a rare complication after transcatheter aortic valve implantation; however, one with a high mortality. We describe the case of a patient with a completely thrombosed transcatheter aortic valve prosthesis 9 months ...
van Ommen, Vincent, Maessen, Jos G.; id_orcid, Kats, Suzanne, Kietselaer, Bas L. J. H., Veenstra, Leo, Poels, Thomas T., Das, Marco   +6 more
core   +1 more source

Early Multicenter Outcomes of Dedicated Transcatheter Aortic Valve Replacement for Left Ventricular Assist Device‐Associated Pure Aortic Regurgitation

Artificial Organs, Volume 50, Issue 10, Page 1427-1433, October 2026.
LVAD‐associated aortic regurgitation impairs circulatory support, with limited surgical and off‐label options. In a multicenter registry (n = 30), the AR‐dedicated JenaValve Trilogy TAVR eliminated AR, achieving 96.7% (29/30) technical success and 93.3% (28/30) device success (VARC‐3), with 3.3% (1/30) 30‐day mortality.
Hristian Hinkov, Sara Yousefzada, Isabell A. Just, Christoph Klein, Evgenij Potapov, Santiago Garcia, Dhairya Patel, Lauren S. Ranard, Arseniy Goncharov, Dean J. Kereiakes, Raj R. Makkar, Torsten P. Vahl, Tanja K. Rudolph, Axel Unbehaun   +13 more
wiley   +1 more source

Late Transcatheter Aortic Valve Thrombotic Obstruction

, 2015
Late valve thrombosis is uncommon after transcatheter aortic valve implantation. Herein, we describe such a complication after transcatheter aortic valve implantation of an Edwards SAPIEN XT aortic bioprosthesis ...
Simon Andreas Müggler, Sabrina Gisler-Jantzen, David Tüller, Jörg Gasser   +3 more
core   +1 more source

Longitudinal Left Atrial Remodeling With Pharmacological Rhythm Versus Rate Control in Paroxysmal and Persistent Atrial Fibrillation

Echocardiography, Volume 43, Issue 10, October 2026.
Among patients with paroxysmal or persistent atrial fibrillation, pharmacological rhythm control was associated with more favorable longitudinal left atrial remodeling than rate control. LAVI increased during rate control but remained stable during rhythm control, with an adjusted 9.38 mL/m2 lower follow‐up LAVI. The association was also observed among
Shao‐Fu Chien, Chih‐Hui Chin, Chao‐Chien Chang, Shih‐Yu Huang, Hung‐Yi Chiou   +4 more
wiley   +1 more source

Second valve implantation for the treatment of a malpositioned transcatheter aortic valve

, 2012
Unfavorable immediate or delayed results after transcatheter aortic valve implantation (TAVI) may be a consequence of bioprosthesis malfunctioning, malpositioning, embolization, or degeneration. Deployment of a second valve within the first one implanted
Windecker, Stephan, Huber, Christoph, Pilgrim, Thomas, Wenaweser, Peter, Guérios, Ênio E, Gloekler, Steffen, Stortecky, Stefan, Büllesfeld, Lutz, Khattab, Ahmed A, Meier, Bernhard   +9 more
core  

Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation

, 2011
Coronary artery disease (CAD) is frequently present in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI).
Thierry Carrel, Windecker, Stephan, Buellesfeld, Lutz, Guerios, Enio, Thomas Pilgrim, Peter Wenaweser, Bernhard Meier, Wenaweser, Peter, Christoph Huber, Stortecky, Stefan, Huber, Christoph, Carrel, Thierry, Stephan Windecker, Steffen Gloekler, Lutz Buellesfeld, Pilgrim, Thomas, Ahmed A. Khattab, Kadner, Alexander, Enio Guerios, Khattab, Ahmed A, Gloekler, Steffen, Meier, Bernhard, Stefan Stortecky, Alexander Kadner, Buellesfeld L, Windecker S, Wenaweser P, Meier B, Khattab AA, Kadner A, Huber C, Guerios E, Pilgrim T, Carrel T, Gloekler S, Stortecky S   +35 more
core   +1 more source

Spotlight on the SAPIEN 3 transcatheter heart valve

Medical Devices: Evidence and Research, 2018
Tobias Rheude,1 Johannes Blumenstein,2 Helge Möllmann,2 Oliver Husser2 1Department of Cardiovascular Diseases, German Heart Centre, Technical University Munich, Munich, Germany; 2Department of Cardiology, St.-Johannes-Hospital, Dortmund, Germany ...
Rheude T, Blumenstein J, Möllmann H, Husser O   +3 more
doaj  

Improvement of physical and mental health after transfemoral transcatheter aortic valve implantation

, 2012
Transcatheter aortic valve implantation (TAVI) has emerged as a treatment alternative to surgical aortic valve replacement in elderly high-risk patients with symptomatic severe aortic stenosis. In this patient population, rapid improvement or restoration
Windecker, Stephan, Buellesfeld, Lutz, Pilgrim, Thomas, Schmid, Valerie, Kadner, Alexander, Wenaweser, Peter, Stortecky, Stefan, Khattab, Ahmed A, Buellesfeld L, Windecker S, Wenaweser, Peter Martin, Pilgrim T, Büllesfeld, Lutz, Khattab, Ahmed Aziz, Wenaweser P, Schmid V, Khattab AA, Kadner A, Stortecky S   +18 more
core   +1 more source

Feasibility, Accuracy, and Reproducibility of Aortic Valve Sizing for Transcatheter Aortic Valve Implantation Using Virtual Reality

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Detailed visualization and precise measurements of aortic valve dimensions are critical for the success of transcatheter aortic valve implantation and for the prevention of complications.
Dominika Kanschik, Jafer Haschemi, Houtan Heidari, Kathrin Klein, Shazia Afzal, Oliver Maier, Kerstin Piayda, Stephan Binneboesssel, Goeksen Oezaslan, Raphael R. Bruno, Gerald Antoch, Artur Lichtenberg, Felix Fleissner, Maximillian Scherner, Malte Kelm, Tobias Zeus, Christian Jung   +16 more
doaj   +1 more source